COMP <GO>
IDYA vs DYN // EV/EBITDA & P/E VALUATION
IDEAYA Biosciences Inc. (NASDAQ) VS. Dyne Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: IDYA 3
— DYN 2
■ METRIC PARITY
LAST: $32.89 (-3.15%) • MKT CAP: $3.17B
valuation
—
LAST: $17.04 (+0.35%) • MKT CAP: $3.18B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IDYA VS. DYN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IDYA | DYN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -13.80% | -35.00% | +21.20 | IDYA | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.31% | -12.73% | +10.42 | IDYA | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -52.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 21.49 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 1/9 | +3.00 | IDYA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.6 | 50.0 | -15.39 | DYN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.17B | $3.18B | -$8.6M | DYN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IDYA REV | DYN REV | IDYA GROSS % | DYN GROSS % | IDYA FCF | DYN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $218.7M | $0 | — | — | -$73.5M | -$405.1M |
| FY 2024 | $7.0M | $0 | — | — | -$251.4M | -$294.7M |
| FY 2023 | $23.4M | $0 | — | — | -$115.2M | -$188.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IDYA // BETA —
DYN // BETA —